📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape. (2020)

First Author: Hamis S

Attributed to: Developing new paradigms for overcoming drug resistance in cancer using novel humanised mouse models funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pcbi.1008041

PubMed Identifier: 32745136

Publication URI: http://europepmc.org/abstract/MED/32745136

Type: Journal Article/Review

Volume: 16

Parent Publication: PLoS computational biology

Issue: 8

ISSN: 1553-734X